Algernon Pharmaceuticals Statistics

Total Valuation

Algernon Pharmaceuticals has a market cap or net worth of CAD 2.18 million. The enterprise value is 1.57 million.

Market Cap	2.18M
Enterprise Value	1.57M

Important Dates

The next estimated earnings date is Tuesday, November 26, 2024.

Earnings Date	Nov 26, 2024
Ex-Dividend Date	n/a

Share Statistics

Algernon Pharmaceuticals has 27.25 million shares outstanding. The number of shares has increased by 129.60% in one year.

Current Share Class	n/a
Shares Outstanding	27.25M
Shares Change (YoY)	+129.60%
Shares Change (QoQ)	+15.96%
Owned by Insiders (%)	12.26%
Owned by Institutions (%)	0.18%
Float	19.43M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	n/a
PB Ratio	0.89
P/TBV Ratio	n/a
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	-0.60
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 0.36

Current Ratio	0.36
Quick Ratio	0.32
Debt / Equity	n/a
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	n/a

Financial Efficiency

Return on equity (ROE) is -91.78% and return on invested capital (ROIC) is -63.27%.

Return on Equity (ROE)	-91.78%
Return on Assets (ROA)	-35.86%
Return on Capital (ROIC)	-63.27%
Revenue Per Employee	n/a
Profits Per Employee	n/a
Employee Count	n/a
Asset Turnover	n/a
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +14.29% in the last 52 weeks. The beta is -0.40, so Algernon Pharmaceuticals's price volatility has been lower than the market average.

Beta (5Y)	-0.40
52-Week Price Change	+14.29%
50-Day Moving Average	0.08
200-Day Moving Average	0.11
Relative Strength Index (RSI)	48.03
Average Volume (20 Days)	24,749

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

Revenue	n/a
Gross Profit	n/a
Operating Income	-2.88M
Pretax Income	-2.61M
Net Income	-2.61M
EBITDA	-2.84M
EBIT	-2.88M
Earnings Per Share (EPS)	-0.12

Full Income Statement

Balance Sheet

Cash & Cash Equivalents	609,524
Total Debt	n/a
Net Cash	609,524
Net Cash Per Share	0.02
Equity (Book Value)	1.96M
Book Value Per Share	0.09
Working Capital	-1.24M

Full Balance Sheet

Cash Flow

Operating Cash Flow	-2.65M
Capital Expenditures	n/a
Free Cash Flow	n/a
FCF Per Share	n/a

Full Cash Flow Statement

Margins

Gross Margin	n/a
Operating Margin	n/a
Pretax Margin	n/a
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

Algernon Pharmaceuticals does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-129.60%
Shareholder Yield	-129.60%
Earnings Yield	-150.80%
FCF Yield	n/a

Stock Splits

The last stock split was on March 3, 2023. It was a forward split with a ratio of 4.

Last Split Date	Mar 3, 2023
Split Type	Forward
Split Ratio	4

Scores

Altman Z-Score	n/a
Piotroski F-Score	n/a